drugset / Trial / NCT00269191

A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)

NCT00269191

Phase 3 Completed 528 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was conducted to assess the safety and tolerability of the drug and to evaluate its efficacy in the treatment of osteoarthritis of the hip or knee in men and women.

Timeline

Start
2003-02-05
Primary completion
2003-11-07
Completion
2003-11-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoricoxib Small molecule 30 mg
Subject Ibuprofen Small molecule 2400 mg

Indications